Summary

The Global IVD Reagents Market is valued at approximately USD 80.72 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of more than 6.80% over the forecast period from 2025 to 2035. In-vitro diagnostic (IVD) reagents are indispensable components in medical diagnostics, enabling clinicians and laboratories to perform accurate, early, and disease-specific tests. These reagents are used in combination with IVD instruments and kits to identify infections, chronic conditions, and genetic predispositions, significantly accelerating the decision-making process for healthcare providers. The proliferation of chronic and infectious diseases, compounded by a global aging population and increasing patient awareness, is propelling the demand for sophisticated and rapid diagnostic solutions — thereby catalyzing the growth of the IVD reagents market globally.
The market’s trajectory is further augmented by ongoing advancements in diagnostics technology, including automation, high-throughput testing, and miniaturization of diagnostic devices. For instance, the rising deployment of molecular diagnostic techniques during and after the COVID-19 pandemic has underscored the need for scalable and efficient reagent formulations. Additionally, the surge in personalized medicine, coupled with rising investments in genomics and biomarker research, has positioned reagents at the epicenter of innovation in healthcare diagnostics. However, the market is not without its restraints — high costs associated with sophisticated reagents and instruments, stringent regulatory frameworks, and reimbursement limitations are some of the headwinds anticipated to pose challenges to rapid expansion.
Geographically, North America held the lion’s share of the global IVD reagents market in 2024, largely due to the region’s robust healthcare infrastructure, early adoption of cutting-edge diagnostic tools, and strong presence of key industry players. The United States, in particular, continues to dominate due to its significant investments in healthcare research and diagnostics innovation. Meanwhile, the Asia Pacific region is expected to witness the fastest CAGR over the forecast period. Nations like China, India, and Japan are driving this growth, owing to their expanding healthcare expenditure, growing population base, increasing burden of chronic diseases, and government-led initiatives to modernize diagnostics capabilities. Europe also remains a pivotal market, supported by widespread screening programs, advanced healthcare access, and collaborative efforts among diagnostic laboratories and biotech companies.
Major market player included in this report are:
• Bio-Rad Laboratories Inc.
• Roche Diagnostics
• Siemens Healthineers
• Thermo Fisher Scientific
• Becton, Dickinson and Company
• Abbott Laboratories
• QuidelOrtho Corporation
• Agilent Technologies
• Biomerieux SA
• Danaher Corporation
• Merck KGaA
• PerkinElmer Inc.
• Hologic Inc.
• GenScript Biotech Corporation
• F. Hoffmann-La Roche Ltd
Global IVD Reagents Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:
By Type:
• Antibodies
• Oligonucleotides
• Nucleic Acid Probes
By Technology:
• Immunoassays
• Clinical Chemistry
• Molecular Diagnostics
By Application:
• Infectious Diseases
• Diabetes
• Oncology
By End-User:
• Hospitals & Clinics
• Blood Banks
• Home Care
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1. Global IVD Reagents Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
 1.2.1. Forecast Model
 1.2.2. Desk Research
 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
 1.4.1. Market Definition
 1.4.2. Market Segmentation
1.5. Research Assumption
 1.5.1. Inclusion & Exclusion
 1.5.2. Limitations
 1.5.3. Years Considered for the Study
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings
Chapter 3. Global IVD Reagents Market Forces Analysis (2024-2035)
3.1. Market Forces Shaping The Global IVD Reagents Market
3.2. Drivers
 3.2.1. Rising global burden of chronic and infectious diseases
 3.2.2. Growing demand for early and accurate diagnosis
3.3. Restraints
 3.3.1. High cost of advanced reagents and diagnostic platforms
 3.3.2. Regulatory challenges and reimbursement constraints
3.4. Opportunities
 3.4.1. Expansion of personalized medicine and biomarker discovery
 3.4.2. Technological advancements in molecular diagnostics
Chapter 4. Global IVD Reagents Industry Analysis
4.1. Porter’s 5 Forces Model
 4.1.1. Bargaining Power of Buyer
 4.1.2. Bargaining Power of Supplier
 4.1.3. Threat of New Entrants
 4.1.4. Threat of Substitutes
 4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
 4.3.1. Political
 4.3.2. Economical
 4.3.3. Social
 4.3.4. Technological
 4.3.5. Environmental
 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis and Trends 2025
4.8. Analyst Recommendation & Conclusion
Chapter 5. Global IVD Reagents Market Size & Forecasts by Type 2025-2035
5.1. Market Overview
5.2. Global IVD Reagents Market Performance - Potential Analysis (2025)
5.3. Antibodies
 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
 5.3.2. Market Size Analysis, by Region, 2025-2035
5.4. Oligonucleotides
 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
 5.4.2. Market Size Analysis, by Region, 2025-2035
5.5. Nucleic Acid Probes
 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
 5.5.2. Market Size Analysis, by Region, 2025-2035
Chapter 6. Global IVD Reagents Market Size & Forecasts by Technology 2025–2035
6.1. Market Overview
6.2. Global IVD Reagents Market Performance - Potential Analysis (2025)
6.3. Immunoassays
 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
 6.3.2. Market Size Analysis, by Region, 2025-2035
6.4. Clinical Chemistry
 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
 6.4.2. Market Size Analysis, by Region, 2025-2035
6.5. Molecular Diagnostics
 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
 6.5.2. Market Size Analysis, by Region, 2025-2035
Chapter 7. Global IVD Reagents Market Size & Forecasts by Application 2025–2035
7.1. Market Overview
7.2. Global IVD Reagents Market Performance - Potential Analysis (2025)
7.3. Infectious Diseases
 7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
 7.3.2. Market Size Analysis, by Region, 2025-2035
7.4. Diabetes
 7.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
 7.4.2. Market Size Analysis, by Region, 2025-2035
7.5. Oncology
 7.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
 7.5.2. Market Size Analysis, by Region, 2025-2035
Chapter 8. Global IVD Reagents Market Size & Forecasts by End-User 2025–2035
8.1. Market Overview
8.2. Global IVD Reagents Market Performance - Potential Analysis (2025)
8.3. Hospitals & Clinics
 8.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
 8.3.2. Market Size Analysis, by Region, 2025-2035
8.4. Blood Banks
 8.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
 8.4.2. Market Size Analysis, by Region, 2025-2035
8.5. Home Care
 8.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
 8.5.2. Market Size Analysis, by Region, 2025-2035
Chapter 9. Global IVD Reagents Market Size & Forecasts by Region 2025–2035
9.1. Global IVD Reagents Market, Regional Market Snapshot
9.2. Top Leading & Emerging Countries
9.3. North America IVD Reagents Market
 9.3.1. U.S.
  9.3.1.1. Type Breakdown Size & Forecasts, 2025-2035
  9.3.1.2. Application Breakdown Size & Forecasts, 2025-2035
 9.3.2. Canada
  9.3.2.1. Type Breakdown Size & Forecasts, 2025-2035
  9.3.2.2. Application Breakdown Size & Forecasts, 2025-2035
9.4. Europe IVD Reagents Market
 9.4.1. UK
  9.4.1.1. Type Breakdown Size & Forecasts, 2025-2035
  9.4.1.2. Application Breakdown Size & Forecasts, 2025-2035
 9.4.2. Germany
 9.4.3. France
 9.4.4. Spain
 9.4.5. Italy
 9.4.6. Rest of Europe
9.5. Asia Pacific IVD Reagents Market
 9.5.1. China
 9.5.2. India
 9.5.3. Japan
 9.5.4. Australia
 9.5.5. South Korea
 9.5.6. Rest of Asia Pacific
9.6. Latin America IVD Reagents Market
 9.6.1. Brazil
 9.6.2. Mexico
9.7. Middle East & Africa IVD Reagents Market
 9.7.1. UAE
 9.7.2. Saudi Arabia
 9.7.3. South Africa
 9.7.4. Rest of Middle East & Africa
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Bio-Rad Laboratories Inc.
  Company Overview
  Key Executives
  Company Snapshot
  Financial Performance (Subject to Data Availability)
  Product/Services Port
  Recent Development
  Market Strategies
  SWOT Analysis
10.3. Roche Diagnostics
10.4. Siemens Healthineers
10.5. Thermo Fisher Scientific
10.6. Becton, Dickinson and Company
10.7. Abbott Laboratories
10.8. QuidelOrtho Corporation
10.9. Agilent Technologies
10.10. Biomerieux SA
10.11. Danaher Corporation
10.12. Merck KGaA
10.13. PerkinElmer Inc.
10.14. Hologic Inc.
10.15. GenScript Biotech Corporation
10.16. F. Hoffmann-La Roche Ltd